Angiodynamics Inc SEC filings ANGO

Angiodynamics Inc has 1,002 filings in SEC EDGAR's recent list, going back to Aug 24, 2011. Its latest annual report, Form 10-K, was filed on Jul 14, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 8, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on May 31.

Angiodynamics Inc SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Oct 21, 2025 —
S-8 Employee stock plan registration Jan 6, 2023 —
S-8 Employee stock plan registration Jan 19, 2021 —
S-8 Employee stock plan registration Feb 22, 2019 —
424B7 Final prospectus supplement Apr 10, 2017 —
424B7 Preliminary prospectus supplement Apr 6, 2017 —
424B7 Final prospectus supplement Nov 16, 2016 —
424B7 Preliminary prospectus supplement Nov 14, 2016 —
424B7 Prospectus supplement Aug 3, 2016 —
424B7 Preliminary prospectus supplement Aug 2, 2016 —
S-8 Employee stock plan registration Apr 16, 2015 —
S-3/A Amendment no. 1 to form s-3 Oct 3, 2013 —
S-3 Shelf registration Aug 15, 2013 —
S-8 Employee stock plan registration Aug 15, 2013 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANGO (Nasdaq)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Latham, NY
SEC filer status
Accelerated filer
SEC CIK
1275187

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.